Richard S. Levy
2012
In 2012, Richard S. Levy earned a total compensation of $1.3M as Executive Vice President and Chief Drug Development and Medical Officer at Incyte, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $212,761 |
|---|---|
| Option Awards | $771,478 |
| Salary | $354,602 |
| Other | $6,569 |
| Total | $1,345,410 |
Levy received $771.5K in option awards, accounting for 57% of the total pay in 2012.
Levy also received $212.8K in non-equity incentive plan, $354.6K in salary and $6.6K in other compensation.
Rankings
In 2012, Richard S. Levy's compensation ranked 4,973rd out of 11,487 executives tracked by ExecPay. In other words, Levy earned more than 56.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,973 out of 11,487 | 57th |
Division Services | 752 out of 1,721 | 56th |
Major group Engineering, Accounting, Research, Management, And Related Services | 60 out of 165 | 64th |
Industry group Research, Development, And Testing Services | 23 out of 56 | 59th |
Industry Commercial Physical and Biological Research | 23 out of 51 | 55th |
Source: SEC filing on April 13, 2015.
Levy's colleagues
We found four more compensation records of executives who worked with Richard S. Levy at Incyte in 2012.